Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IndoVac Homologous Booster for COVID-19
NCT05933278Phase 2Completed
- Sponsor
- Bio Farma
- Start
- Jul 2023
- Primary completion
- Aug 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of IndoVac in coronavirus disease 2019 (COVID-19), sponsored by Bio Farma. Started Jul 2023; status: completed.
02
Drugs
IndoVac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05933278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05933278.